Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer | Health Disparities | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
1.
Siegel  RL, Miller  KD, Jemal  A.  Cancer statistics, 2015.  CA Cancer J Clin. 2015;65(1):5-29.PubMedGoogle ScholarCrossref
2.
Rahib  L, Smith  BD, Aizenberg  R, Rosenzweig  AB, Fleshman  JM, Matrisian  LM.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.  Cancer Res. 2014;74(11):2913-2921.PubMedGoogle ScholarCrossref
3.
Zell  JA, Rhee  JM, Ziogas  A, Lipkin  SM, Anton-Culver  H.  Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.  Cancer Epidemiol Biomarkers Prev. 2007;16(3):546-552.PubMedGoogle ScholarCrossref
4.
Bilimoria  KY, Bentrem  DJ, Ko  CY, Stewart  AK, Winchester  DP, Talamonti  MS.  National failure to operate on early stage pancreatic cancer.  Ann Surg. 2007;246(2):173-180.PubMedGoogle ScholarCrossref
5.
Riall  TS, Townsend  CM  Jr, Kuo  YF, Freeman  JL, Goodwin  JS.  Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.  Cancer. 2010;116(4):930-939.PubMedGoogle ScholarCrossref
6.
Baine  M, Sahak  F, Lin  C, Chakraborty  S, Lyden  E, Batra  SK.  Marital status and survival in pancreatic cancer patients: a SEER based analysis.  PLoS One. 2011;6(6):e21052.PubMedGoogle ScholarCrossref
7.
Aizer  AA, Chen  MH, McCarthy  EP,  et al.  Marital status and survival in patients with cancer.  J Clin Oncol. 2013;31(31):3869-3876.PubMedGoogle ScholarCrossref
8.
Smith  JK, Ng  SC, Zhou  Z,  et al.  Does increasing insurance improve outcomes for US cancer patients?  J Surg Res. 2013;185(1):15-20.PubMedGoogle ScholarCrossref
9.
McGhan  LJ, Etzioni  DA, Gray  RJ, Pockaj  BA, Coan  KE, Wasif  N.  Underuse of curative surgery for early stage upper gastrointestinal cancers in the United States.  J Surg Res. 2012;177(1):55-62.PubMedGoogle ScholarCrossref
10.
Murphy  MM, Simons  JP, Hill  JS,  et al.  Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.  Cancer. 2009;115(17):3979-3990.PubMedGoogle ScholarCrossref
11.
Murphy  MM, Simons  JP, Ng  SC,  et al.  Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.  Ann Surg Oncol. 2009;16(11):2968-2977.PubMedGoogle ScholarCrossref
12.
Shah  A, Chao  KS, Ostbye  T,  et al.  Trends in racial disparities in pancreatic cancer surgery.  J Gastrointest Surg. 2013;17(11):1897-1906.PubMedGoogle ScholarCrossref
13.
Shavers  VL, Harlan  LC, Jackson  M, Robinson  J.  Racial/ethnic patterns of care for pancreatic cancer.  J Palliat Med. 2009;12(7):623-630.PubMedGoogle ScholarCrossref
14.
Singal  V, Singal  AK, Kuo  YF.  Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.  J Cancer Res Clin Oncol. 2012;138(4):715-722.PubMedGoogle ScholarCrossref
15.
Silverman  DT, Hoover  RN, Brown  LM,  et al.  Why do black Americans have a higher risk of pancreatic cancer than white Americans?  Epidemiology. 2003;14(1):45-54.PubMedGoogle ScholarCrossref
16.
Abraham  A, Al-Refaie  WB, Parsons  HM, Dudeja  V, Vickers  SM, Habermann  EB.  Disparities in pancreas cancer care.  Ann Surg Oncol. 2013;20(6):2078-2087.PubMedGoogle ScholarCrossref
17.
Edwards  BK, Noone  AM, Mariotto  AB,  et al.  Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.  Cancer. 2014;120(9):1290-1314.PubMedGoogle ScholarCrossref
18.
Eppsteiner  RW, Csikesz  NG, McPhee  JT, Tseng  JF, Shah  SA.  Surgeon volume impacts hospital mortality for pancreatic resection.  Ann Surg. 2009;249(4):635-640.PubMedGoogle ScholarCrossref
Original Investigation
Association of VA Surgeons
April 2016

Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer

Author Affiliations
  • 1Harvard Medical School, Boston, Massachusetts
  • 2Surgery Service, VA Boston Healthcare System, Boston, Massachusetts
  • 3Research Service, VA Boston Healthcare System, Boston, Massachusetts
  • 4Boston University School of Medicine, Boston, Massachusetts
  • 5Pathology Service, VA Boston Healthcare System, Boston, Massachusetts
  • 6Medicine Service, VA Boston Healthcare System, Boston, Massachusetts
  • 7Brigham and Women’s Hospital, Boston, Massachusetts
  • 8Harvard Vanguard Medical Associates, Boston, Massachusetts
  • 9Beth Israel Deaconess Medical Center, Boston, Massachusetts
JAMA Surg. 2016;151(4):338-345. doi:10.1001/jamasurg.2015.4239
Abstract

Importance  Socioeconomic variables including sex, race, ethnicity, marital status, and insurance status are associated with survival in pancreatic cancer. It remains unknown exactly how these variables influence survival, including whether they affect stage at presentation or receipt of treatment or are independently associated with outcomes.

Objectives  To investigate the relationship between socioeconomic factors and odds of resection in early-stage, resectable pancreatic adenocarcinoma and to determine whether these same factors were independently associated with survival in patients who underwent resection.

Design, Setting, and Participants  This was a retrospective cohort study of patients diagnosed as having T1 through T3 M0 pancreatic adenocarcinoma between January 1, 2004, and December 31, 2011, identified from the Surveillance, Epidemiology, and End Results database.

Main Outcomes and Measures  Socioeconomic and geographic variables associated with utilization of resection and disease-specific survival.

Results  A total of 17 530 patients with localized, nonmetastatic pancreatic cancer were identified. The resection rate among these patients was 45.4% and did not change over time. Utilization of resection was independently associated with white vs African American race (odds ratio [OR] = 0.76; 95% CI, 0.65-0.88; P < .001), non-Hispanic ethnicity (for Hispanic, OR = 0.72; 95% CI, 0.60-0.85; P < .001), married status (OR = 1.42; 95% CI, 1.30-1.57; P < .001), insurance coverage (OR = 1.63; 95% CI, 1.22-2.18; P = .001), and the Northeast region (vs Southeast, OR = 1.67; 95% CI, 1.44-1.94; P < .001). Stage at presentation correlated with sex, race, ethnicity, marital status, and geographic region (ethnicity, P = .003; all others, P < .001); however, the factors associated with increased resection correlated with more advanced stage. Patients who underwent resection had significantly improved disease-specific survival compared with those who did not undergo resection (median, 21 vs 6 months; hazard ratio [HR] for disease-specific death = 0.32; 95% CI, 0.31-0.33; P < .001). Disease-specific survival among the patients who underwent surgical resection was independently associated with geographic region, with patients in the Pacific West (HR for death = 0.706; 95% CI, 0.628-0.793), Northeast (HR for death = 0.766; 95% CI, 0.667-0.879), and Midwest (HR for death = 0.765; 95% CI, 0.640-0.913) having improved survival in comparison with those in the Southeast (all P < .001).

Conclusions and Relevance  Disparities in the utilization of surgical resection for patients with early-stage, resectable pancreatic cancer are associated with socioeconomic variables including race, ethnicity, marital status, insurance status, and geographic location. Of these factors, only geographic location is independently associated with survival in patients undergoing resection.

×